scholarly journals Quality of Life and Its Associated Factors in Patients with Hepatocellular Carcinoma Receiving One Course of Transarterial Chemoembolization Treatment: A Longitudinal Study

2012 ◽  
Vol 17 (5) ◽  
pp. 732-739 ◽  
Author(s):  
Shiow‐Ching Shun ◽  
Chien‐Hung Chen ◽  
Jin‐Chuan Sheu ◽  
Ja‐Der Liang ◽  
Jyh‐Chin Yang ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Longitudinal Study ◽  
Transarterial Chemoembolization ◽  
Associated Factors

scholarly journals Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

HPB Surgery ◽  
2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Saleem Ahmed ◽  
Nurun Nisa de Souza ◽  
Wang Qiao ◽  
Meidai Kasai ◽  
Low Jee Keem ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Transarterial Chemoembolization ◽  
Palliative Therapy ◽  
Advanced Stages ◽  
The Impact

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients.

Sign in / Sign up

Export Citation Format

Share Document